Management of high-grade dysplasia

Current Gastroenterology Reports

Volumn 10, Issue 3, 2008, Pages 240-245

  Palazzo, Francesco ^a   Fisichella, Piero M ^a   Patti, Marco G ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER GROWTH; CANCER RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTROINTESTINAL DYSPLASIA; HIATUS HERNIA; HIGH GRADE DYSPLASIA; HIGH RISK PATIENT; HUMAN; LOW LEVEL LASER THERAPY; MONOTHERAPY; OVERALL SURVIVAL; PHOTODYNAMIC THERAPY; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL APPROACH; ELECTROCOAGULATION; PATHOLOGY; PHOTOCHEMOTHERAPY;

BARRETT ESOPHAGUS; ELECTROCOAGULATION; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; PHOTOCHEMOTHERAPY;

EID: 54049119322     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0050-7     Document Type: Review

References (43)

1. Wu PC, Posner MC: The role of surgery in the management of esophageal cancer. Lancet Oncol 2003, 4:481-488.
2. Falk GW: Barrett's esophagus. Gastroenterology 2002, 122:1569-1591.
3. Spechler SJ: Clinical practice. Barrett's esophagus. N Engl J Med 2002, 346:836-842.
4. Flejou JF, Svrcek M: Barrett's oesophagus - a pathologist's view. Histopathology 2007, 50:3-14.
5. Weston AP, Sharma P, Topalovski M, et al.: Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000, 95:1888-1893.
6. Reid BJ, Blount PL, Feng Z, Levine DS: Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 2000, 95:3089-3096.
7. Altorki NK, Skinner DB: Adenocarcinoma in Barrett's esophagus. Semin Surg Oncol 1990, 6:274-278.
8. Riddell RH, Goldman H, Ransohoff DF, et al.: Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983, 14:931-968.
9. Geboes K, Van Eyken P: The diagnosis of dysplasia and malignancy in Barrett's osophagus. Histopathology 2000, 37:99-107.
10. Overholt BF, Lightdale CJ, Wang KK, et al.: Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62:488-498.
11. Ormsby AH, Petras RE, Henricks WH, et al.: Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 2002, 51:671-676.
12. Weston AP, Krmpotich PT, Cherian R, et al.: Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997, 92:407-413.
13. Weston AP, Sharma P, Mathur S, et al.: Risk stratification of Barrett's esophagus: Updated prospective multivariate analysis. Am J Gastroenterol 2004, 99:1657-1666.
14. Avidan B, Sonnenberg A, Schnell TG, et al.: Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002, 97:1930-1936.
15. Buttar NS, Wang KK, Sebo TJ, et al.: Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001, 120:1630-1639.
16. Tharavej C, Hagen JA, Peters JH, et al.: Predictive factors of coexisting cancer in Barrett's high-grade dysplasia. Surg Endosc 2006, 20:439-443.
17. Chow WH, Blaser MJ, Blot WJ, et al.: An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998, 58:588-590.
18. Reid BJ, Levine DS, Longton G, et al.: Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low-and high-risk patient subsets. Am J Gastroenterol 2000, 95:1669-1676.
19. Levine DS, Haggitt RC, Blount PL, et al.: An endoscopic biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993, 105:40-50.
20. Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology: Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002, 97:1888-1895.
21. Tytgat GN, Bartelink H, Bernards R, et al.: Cancer of the esophagus and gastric cardia: Recent advances. Dis Esophagus 2004, 17:10-26.
22. Jamieson GG, Mathew G, Ludemann R, et al.: Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004, 91:943-947.
23. Bailey SH, Bull DA, HarpAle DH, et al.: Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003, 75:217-222.
24. Williams VA, Watson TJ, Herbella FA, et al.: Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg 2007, 11:1589-1597.
25. Patti MG, Corvera CU, Glasgow RE, Way LW: A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg 1998, 2:186-192.
26. Swisher SG, Deford L, Merriman KW, et al.: Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000, 119:1126-1132.
27. Chang LC, Oelschlager BK, Quiroga E, et al.: Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus. J Gastrointest Surg 2006, 10:341-346.
28. Smithers BM, Gotley DC, Martin I, Thomas JM: Comparison of outcomes between open and minimally invasive esophagectomy. Ann Surg 2007, 245:232-240.
29. Braghetto I, Csendes A, Cardemil G, et al.: Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc 2006, 20:1681-1686.
30. Peyre CG, DeMeester SR, Rizzetto C, et al.: Vagal-sparing esophagectomy. The ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 2007, 246:665-674.
31. Feith M, Stein HJ, Siewert JR: Pattern of lymphatic spread of Barrett's cancer. World J Surg 2003, 27:1052-1057.
32. Seewald S, Ang TL, Soehendra N: Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer. Postgrad Med J 2007, 83:367-372.
33. Ell C, May A, Gossner L, et al.: Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118:670-677.
34. May A, Gossner L, Pech O, et al.: Local endoscopic therapy for intraepithelial high grade neoplasia and early adenocarcinoma in Barrett's esophagus: Acute phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002, 14:1085-1091.
35. Conio M, Repici A, Cestari R, et al.: Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 2005, 11:6650-6655.
36. Prasad GA, Buttar NS, Wongkeesong LM, et al.: Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol 2007, 102:2380-2386.
37. Johnston MH, Eastone JA, Horwhat JD, et al.: Cryoablation of Barrett's esophagus: A pilot study. Gastrointest Endosc 2005, 62:842-848.
38. Mino-Kenudson M, Ban S, Ohana M, et al.: Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007, 31:403-409.
39. Prasad GA, Wang KK, Buttar NS, et al.: Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007, 132:1226-1233.
40. Ganz RA, Utley DS, Stern RA, et al.: Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: A phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004, 60:1002-1010.
41. Sharma VK, Wang KK, Overholt BF, et al.: Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007, 65:185-195.
42. Roorda AK, Marcus SN, Triadafilopoulos G: Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007, 20:516-522.
43. Smith CD, Bejarano PA, Melvin WS, et al.: Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007, 21:560-569.